Patents by Inventor Ibrahim Abdullah

Ibrahim Abdullah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF HDAC AND/OR DNMT INHIBITORS FOR TREATMENT OF ISCHEMIC INJURY
    Publication number: 20170027971
    Abstract: The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
    Type: Application
    Filed: July 18, 2016
    Publication date: February 2, 2017
    Inventors: Peter J. GRUBER, Jonathan A. EPSTEIN, Ibrahim ABDULLAH
  • Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury
    Patent number: 9393222
    Abstract: The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: July 19, 2016
    Assignees: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, CHILDREN'S HOSPITAL OF PHILADELPHIA
    Inventors: Peter J. Gruber, Jonathan A. Epstein, Ibrahim Abdullah
  • Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury
    Patent number: 8889742
    Abstract: The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: November 18, 2014
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Peter J. Gruber, Jonathan A. Epstein, Ibrahim Abdullah
  • USE OF HDAC AND/OR DNMT INHIBITORS FOR TREATMENT OF ISCHEMIC INJURY
    Publication number: 20140107211
    Abstract: The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
    Type: Application
    Filed: December 16, 2013
    Publication date: April 17, 2014
    Inventors: Peter J. GRUBER, Jonathan A. EPSTEIN, Ibrahim ABDULLAH
  • Use Of HDAC And/Or DNMT Inhibitors For Treatment Of Ischemic Injury
    Publication number: 20090105168
    Abstract: The present invention provides methods of ameliorating or reducing the extent of ischemic injury, reperfusion injury, and myocardial infarction, by administering an inhibitor of histone deacetylase enzyme (HDAC) or an inhibitor of DNA methyltransferase enzyme (DNMT).
    Type: Application
    Filed: November 30, 2005
    Publication date: April 23, 2009
    Inventors: Peter J. Gruber, Jonathan A. Epstein, Ibrahim Abdullah
  • Meta-protocol
    Publication number: 20060036755
    Abstract: The present invention teaches a multi-layer protocol management system and method, embeddable in a tangible computer-readable medium, that allow for on-the-fly machine-readable protocol discovery and negotiation, distribution of protocol specifications and components, automatic implementation of protocols from corresponding machine-readable protocol specifications, and corresponding execution of automatically generated implementations. Automatic protocol implementation may be accomplished using eXtensible Markup Language (XML)-related technologies and Component-based Software Engineering (CBSE). The present invention is also a tangible computer-readable medium encoded with instructions capable of generating, as well as capable of being designed to generate, protocol specifications. A program of instructions, called XML-based protocol specification language (XPSL), may be used for creating a specification of a communication protocol (such as high-level specifications of a protocol) in a machine readable form.
    Type: Application
    Filed: May 5, 2005
    Publication date: February 16, 2006
    Inventors: Ibrahim Abdullah, Daniel Menasce